Opexa Therapeutics (OPXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | OPXA | AMGN | CELG | GILD | BIIB |
Company | Opexa Therapeutics | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 1.15 | 287.86 | 108.01 | 73.25 | 217.36 |
High | 1.16 | 288.50 | 108.59 | 73.58 | 217.44 |
Low | 0.96 | 287.84 | 107.27 | 73.24 | 216.44 |
Last | 0.97 | 287.32 | 108.24 | 73.61 | 216.65 |
Change | -0.10 | +1.02 | +0.11 | +0.60 | +0.31 |
% Change | -9.35% | +0.36% | +0.10% | +0.82% | +0.14% |
Volume | 307,200 | 55,206 | 191,230,496 | 163,722 | 16,300 |
20-Day Average Volume | 233,245 | 2,843,700 | 16,188,930 | 7,056,921 | 1,228,535 |
Previous Close | 1.07 | 286.30 | 108.13 | 73.01 | 216.34 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | No | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 0.93 | 276.68 | 108.17 | 73.54 | 219.95 |
20-Day Raw Stochastic | 47.22% | 97.81% | 63.25% | 32.24% | 29.58% |
20-Day Relative Strength | 54.95% | 55.29% | 64.69% | 45.30% | 41.33% |
Weighted Alpha | -17.12 | +19.51 | +46.30 | -11.94 | -25.04 |
Today's Opinion | N/A | 48% Buy | 100% Buy | 88% Sell | 100% Sell |
Previous Opinion | N/A | 40% Buy | 100% Buy | 88% Sell | 100% Sell |
Last Month's Opinion | N/A | 24% Buy | 100% Buy | 40% Sell | 88% Sell |
Performance | |||||
5-Days | |||||
%Chg | -1.02% since 09/13/17 | +4.01% since 03/21/24 | -1.97% since 11/13/19 | +0.33% since 03/21/24 | -1.84% since 03/21/24 |
Low | 0.96 on 09/20/17 | 275.10 on 03/22/24 | 107.27 on 11/20/19 | 72.11 on 03/26/24 | 211.01 on 03/26/24 |
High | 1.16 on 09/20/17 | 288.50 on 03/28/24 | 110.53 on 11/14/19 | 73.58 on 03/28/24 | 221.30 on 03/22/24 |
1-Month | |||||
%Chg | +29.33% since 08/18/17 | +3.82% since 02/28/24 | +5.14% since 10/18/19 | +0.87% since 02/28/24 | -2.28% since 02/28/24 |
Low | 0.74 on 08/21/17 | 268.17 on 03/15/24 | 102.40 on 10/21/19 | 71.92 on 02/29/24 | 211.01 on 03/26/24 |
High | 1.16 on 09/20/17 | 288.50 on 03/28/24 | 110.70 on 11/13/19 | 76.21 on 03/11/24 | 230.22 on 03/11/24 |
3-Month | |||||
%Chg | +64.41% since 06/20/17 | -0.14% since 12/28/23 | +13.63% since 08/20/19 | -9.63% since 12/28/23 | -16.84% since 12/28/23 |
Low | 0.55 on 06/22/17 | 268.17 on 03/15/24 | 93.41 on 08/23/19 | 71.37 on 02/16/24 | 211.01 on 03/26/24 |
High | 1.45 on 07/05/17 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
6-Month | |||||
%Chg | +14.12% since 03/20/17 | +6.36% since 09/28/23 | +14.14% since 05/20/19 | -2.77% since 09/28/23 | -15.95% since 09/28/23 |
Low | 0.55 on 06/22/17 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 71.37 on 02/16/24 | 211.01 on 03/26/24 |
High | 1.45 on 07/05/17 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 269.43 on 10/17/23 |
Key Statistics | |||||
Market Capitalization, $K | 7,430 | 153,433,600 | 77,035,920 | 90,903,080 | 31,447,398 |
Shares Outstanding, K | 7,660 | 535,919 | 711,714 | 1,245,077 | 145,361 |
Annual Sales | 2,910,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
Annual Net Income | -7,980,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
Last Quarter Sales | 0 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
Last Quarter Net Income | -930,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
60-Month Beta | 2.05 | 0.58 | 1.41 | 0.18 | -0.03 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 2.95 on 02/13/24 |
Latest Earnings Date | 11/13/17 | 04/25/24 | 10/31/19 | 04/25/24 | 04/23/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 15.11 | 10.99 | 10.78 | 14.39 |